» Authors » Cheryl N McMahill-Walraven

Cheryl N McMahill-Walraven

Explore the profile of Cheryl N McMahill-Walraven including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 644
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng Y, Hayes K, Zhao Y, Chachlani P, Zullo A, Djibo D, et al.
Vaccine . 2024 Nov; 43(Pt 2):126501. PMID: 39515194
Introduction: Racial and ethnic disparities in COVID-19 vaccine access are well-documented; however, few studies have examined whether racial disparities are modified by other factors, including geographic location and area-level deprivation....
2.
Mai X, Mendelsohn A, Marshall J, Lin N, McDermott C, Ko J, et al.
J Manag Care Spec Pharm . 2024 Sep; 30(10):1160-1166. PMID: 39321121
Background: Trastuzumab is an antihuman epidermal growth factor receptor 2 monoclonal antibody used to treat breast and other cancers. Trastuzumab biosimilars were approved in the United States beginning in 2017....
3.
Kluberg S, Simon A, Alam S, Peters A, Horgan C, Li D, et al.
Semin Arthritis Rheum . 2024 Jul; 68:152518. PMID: 39079205
Objective: To assess whether recombinant zoster vaccine (RZV) is associated with an increased risk of new-onset gout among US adults aged ≥50 years. Methods: We conducted a real-world, retrospective safety...
4.
Wen K, Harris D, Chachlani P, Hayes K, McCarthy E, Zullo A, et al.
Health Aff (Millwood) . 2024 May; 43(5):659-665. PMID: 38709973
We investigated county-level variation in mRNA COVID-19 vaccine use among Medicare beneficiaries throughout the United States. There was greater use of Pfizer-BioNTech vaccines than Moderna vaccines in urban areas for...
5.
Ogilvie R, Layton J, Lloyd P, Jiao Y, Djibo D, Wong H, et al.
BMC Pediatr . 2024 Apr; 24(1):276. PMID: 38671379
Background: COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study's objective was to estimate the effectiveness...
6.
Hu M, Shoaibi A, Feng Y, Lloyd P, Wong H, Smith E, et al.
JAMA Netw Open . 2024 Apr; 7(4):e248192. PMID: 38656578
Importance: Active monitoring of health outcomes after COVID-19 vaccination provides early detection of rare outcomes that may not be identified in prelicensure trials. Objective: To conduct near-real-time monitoring of health...
7.
Akenroye A, Marshall J, Simon A, Hague C, Costa R, Jamal-Allial A, et al.
J Allergy Clin Immunol Pract . 2024 Mar; 12(6):1568-1574.e2. PMID: 38431251
Background: Evidence on the comparative effectiveness of respiratory biologics remains sparse. Objective: We sought to evaluate the comparative effectiveness of omalizumab, mepolizumab, benralizumab, and dupilumab in a matched retrospective cohort...
8.
Harris D, Chachlani P, Hayes K, McCarthy E, Wen K, Deng Y, et al.
Am J Prev Med . 2024 Feb; 67(1):67-78. PMID: 38401746
Introduction: Coadministering COVID-19 and influenza vaccines is recommended by public health authorities and intended to improve uptake and convenience; however, the extent of vaccine coadministration is largely unknown. Investigations into...
9.
Lloyd P, Lufkin B, Moll K, Ogilvie R, McMahill-Walraven C, Beachler D, et al.
Vaccine . 2024 Feb; 42(8):2004-2010. PMID: 38388240
Background: Increased risk of thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector-based COVID-19 vaccinations has been identified in passive surveillance systems. TTS incidence rates (IRs) in the United States (U.S.)...
10.
Cozen A, Carton T, Hamad R, Kornak J, Faulkner Modrow M, Peyser N, et al.
PLoS One . 2024 Feb; 19(2):e0297922. PMID: 38319951
COVID-19 increased the prevalence of clinically significant anxiety in the United States. To investigate contributing factors we analyzed anxiety, reported online via monthly Generalized Anxiety Disorders-7 (GAD-7) surveys between April...